Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke.
Stephanie L HarrisonBenjamin J R BuckleyDeirdre A LaneElnara Fazio-EynullayevaPaula UnderhillAndrew HillDavid J WerringGregory Y H LipPublished in: Cardiovascular drugs and therapy (2023)
The results suggest for patients with AF and carotid artery disease after ischaemic stroke, receiving NOACs without APA is associated with a lower risk of major bleeding with no negative impact on recurrent stroke or mortality. Evidence from randomised trials is needed to confirm this finding.